Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis
Titel:
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis
Auteur:
Saad, Everardo D Squifflet, Pierre Burzykowski, Tomasz Quinaux, Emmanuel Delaloge, Suzette Mavroudis, Dimitris Perez, Edith Piccart-Gebhart, Martine Schneider, Bryan P Slamon, Dennis Wolmark, Norman Buyse, Marc